MedPath

Safety Study of Colonoscopy Under Sedation

Phase 4
Terminated
Conditions
Colonoscopy Procedure
Interventions
Drug: MEOPA
Drug: general anaesthesia
Registration Number
NCT00930358
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Brief Summary

The aim of this study was to compare the analgesia provided by nitrous oxide/oxygen sedation or general anesthesia for colonoscopy

Detailed Description

The purpose of this protocol is to compare two methods of analgesia/sedation for colonoscopy. Sedation and analgesia induced by a 50% nitrous oxide/oxygen mixture could sufficient to allow the practice of colonoscopy instead of general anesthesia which is accompanied with certain risks and post procedure drowsiness.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
220
Inclusion Criteria
  1. Patient referred for colonoscopy with general anesthesia
  2. Age above 18 et below 75 year
  3. Patient who gave an informed consent
Read More
Exclusion Criteria
  1. Age below 18 ou above 75

  2. Need for gastroscopy in the same procedure than colonoscopy

  3. History of surgery wih resection more extended than half of the colon

  4. Dementia with autonomy loss or psychiatric disorder non controlled by therapeutic

  5. Severe congestive heart failure or evolutive heart ischemia

  6. Recent cerebral stroke

  7. Hemodynamic instability

  8. Respiratory failure, severe chronic obstructive pulmonary (including asthma) or progressive pneumothorax

  9. Hepatic failure (Child-Pugh score> 9)

  10. Terminal renal failure 11 Hematopoietic disorders

  11. Pathology with expected survival shorter than the duration of the study and cancer excepted basal cell carcinoma of the skin 13. Alcohol consumption higher than 100 gr per day 14. Pregnancy or breastfeeding at the inclusion period

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
MEOPAMEOPAMEOPA : equimolar nitrous oxide/oxygen mixture
General anesthesiageneral anaesthesiaGold standard
Primary Outcome Measures
NameTimeMethod
Percentage of patients who have well tolerated the colonoscopy as assessed by visual analogic scale (>75/100)Immediately after the colonoscopy
The mean grade of patient anxiety before endoscopyAfter the colonoscopy

The mean grade of patient anxiety before endoscopy

Secondary Outcome Measures
NameTimeMethod
The mean tolerability of the colonoscopy between the group with sedation by nitrous oxide/oxygen mixture and the group with anesthesiaafter the colonoscopy
The mean pain intensity during the procedure on a visual analogic scaleafter the colonoscopy
The mean patient satisfaction on a visual analogic scale.after the colonoscopy
The percentage of patients who agree to repeat the procedure in similar circumstances.after the colonoscopy
The grade of difficulty of the colonoscopy evaluated by the endoscopistAfter the colonoscopy
The mean duration of the endoscopyAfter the colonoscopy
The percentage of caecum intubationAfter the colonoscopy
The percentage of ileal intubationAfter the colonoscopy
The opinion of the endoscopist on the tolerance of the colonoscopyAfter the colonoscopy
The time to hospital dischargeAfter the issue of the colonoscopy
The Aldrete's score at the hospital dischargeAfter the colonoscopy
The number of patient who have refused the inclusionAfter the issue of the colonoscopy

Trial Locations

Locations (1)

Hotel Dieu Hospital

🇫🇷

Paris, France

© Copyright 2025. All Rights Reserved by MedPath